Botulinum toxin polypeptides and their use as vaccine...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/33 (2006.01) A61K 39/08 (2006.01) A61K 39/39 (2006.01) C07K 7/08 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2158748

A short polypeptide, typically in the range 7-35 amino acid residues, that contains a Botulinum toxin T cell epitope and is useful for administration to a mammal as part of a vaccination therapy. Following administration of the polypeptide, an individual has an enhanced response to known botulinum toxin vaccines, such as toxoid vaccine; thus the effects of the vaccine can be improved and increased. Polypeptide formulations and vaccination methods are described.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Botulinum toxin polypeptides and their use as vaccine... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Botulinum toxin polypeptides and their use as vaccine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Botulinum toxin polypeptides and their use as vaccine... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1957875

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.